<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03958513</url>
  </required_header>
  <id_info>
    <org_study_id>BSMMU/2018/12652</org_study_id>
    <nct_id>NCT03958513</nct_id>
  </id_info>
  <brief_title>To Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy</brief_title>
  <official_title>Randomized, Double- Blind, Controlled Trial to Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of wound infiltration with 0.25% Bupivacaine in laparoscopic
      cholecystectomy in terms of pain severity, patient satisfaction level, quality of life,
      hospital stay and return to job and normal activities.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain: VAS</measure>
    <time_frame>12 hours</time_frame>
    <description>Post-operative pain in visual analog scale ranging 0 to100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative pain: rating scale</measure>
    <time_frame>12 HOURS</time_frame>
    <description>Post-operative pain in numerical rating scale ranging 0 to 4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Level: questionnaire</measure>
    <time_frame>24 hour</time_frame>
    <description>Patient Satisfaction Level is measured with revised american pain society outcome questionnaire. 12 questions are present.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>3-5 days</time_frame>
    <description>Time frame for hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during hospital discharge: VAS</measure>
    <time_frame>3-5days</time_frame>
    <description>visual analog scale score during hospital discharge rangibg 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time taken to return to job and normal activities</measure>
    <time_frame>15-30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assesment of quality of life: index</measure>
    <time_frame>15th and 30th post-operative day</time_frame>
    <description>Quality of life is measured with gastrointestinal quality of life index. there are 36 questions . it will measure quality of life after surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% normal saline, 1.5 ml for 1 inch incision, before closure of ports in patients undergoing Laparoscopic Cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.25% Bupivacaine, 1.5 ml per 1 inch incision, before closure of ports in patients undergoing Laparoscopic Cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>1.5 ml 0.25% bupivacaine for 1 inch incision will be given before closure of ports in patients undergoing laparoscopic cholecystectomy</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% normal saline</intervention_name>
    <description>1.5 ml 0.9% NACl for 1 inch incision will be given before closure of ports in patients undergoing laparoscopic cholecystectomy</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Patients scheduled to undergo laparoscopic cholecystectomy under general anesthesia at
             department of surgery and department of hepatobiliary system, BSMMU

          -  Patients who are eligible according to ASA Ⅰ -Ⅱ

          -  Female or male, age ≥18 years

          -  Patients who are scheduled for same anesthetic technique and surgical procedure for
             laparoscopic cholecystectomy

          -  Discharge of patient between 12 hour to 36 hour after performing procedure

          -  Patients given consent for enrollment in study

        Exclusion criteria

          -  Patients known to be allergic to certain recommended drugs

          -  If patients have history of psychiatric illness

          -  Patients on chronic analgesic therapy for any other indication

          -  Patients who are scheduled for different anesthetic technique and surgical procedure
             for laparoscopic cholecystectomy

          -  Duration of surgery more than 1 hour

          -  Patients undergoing laparoscopic cholecystectomy for complex gallbladder disease such
             as incidental gallbladder pancreatitis, gallstone pancreatitis, cholecystoduodenal
             fistula, mirizzi syndrome

          -  Special population group such as children, pregnant woman, patients with cirrhosis,
             diabetics

          -  Duration of operative procedure more than 1 hour
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bangabandhu Sheikh Mujib Medical University</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 15, 2019</study_first_submitted>
  <study_first_submitted_qc>May 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2019</study_first_posted>
  <last_update_submitted>May 29, 2020</last_update_submitted>
  <last_update_submitted_qc>May 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</investigator_affiliation>
    <investigator_full_name>Dr. Monira Parveen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

